Raymond James Financial’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.51M Buy
797,794
+96,705
+14% +$1.39M ﹤0.01% 2066
2025
Q4
$10.8M Sell
701,089
-132,548
-16% -$2.44M ﹤0.01% 1901
2025
Q3
$18M Buy
833,637
+215,377
+35% +$4.8M 0.01% 1485
2025
Q2
$13.7M Buy
618,260
+21,098
+4% +$469K ﹤0.01% 1634
2025
Q1
$14.2M Buy
597,162
+118,674
+25% +$2.81M 0.01% 1550
2024
Q4
$10.1M Buy
+478,488
New +$12.6M ﹤0.01% 1834

Other funds holding SGRY

Raymond James Financial's SGRY Position: Q1 2026 in Review

Raymond James Financial increased its Surgery Partners (SGRY) stake by 14% in Q1 2026, buying an estimated $1.39M and bringing the position to 797,794 shares worth $9.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

Raymond James Financial first reported a position in SGRY in Q4 2024 and has held it in 6 quarters since. The position peaked at $18M in Q3 2025. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Raymond James Financial held 797,794 shares of Surgery Partners worth $9.51M as of Q1 2026.
  • Raymond James Financial bought 96,705 Surgery Partners shares in Q1 2026, an estimated $1.39M.
  • Surgery Partners made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2066 holding.
  • Raymond James Financial first reported a position in Surgery Partners in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Surgery Partners position peaked at $18M in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.